Skip to main content
Clinical Trials/CTRI/2017/01/007747
CTRI/2017/01/007747
Recruiting
未知

A prospective observational study to determine the risk of Hepatitis B viral reactivation in adolescent and adult acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LbL) with Occult Hepatitis B infection (OHBI). - OHBI

Tata Memorial Centre0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Adult acute lymphoblastic leukemia/Lymphoblastic lymphoma
Sponsor
Tata Memorial Centre
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed Patients of Acute lymphoblastic leukemia/lymphoblastic lymphoma aged \>\= 15 years.
  • 2\. Treated on standard ALL protocol such as BFM 90 protocol.
  • 3\. Occult Hepatitis B infection.
  • 4\. Normal Liver function tests (AST/ALT \<50 U/L) unless the derangement can be explained by ALL.
  • 5\. Those who give a written informed consent.

Exclusion Criteria

  • Patients with Hepatitis C viral co\-infection.
  • 2\. Patients with Human immunodeficiency virus co\-infection.
  • 3\. Patients with history of Hepatitis B vaccination (if anti HBs titre is \>5U/L).

Outcomes

Primary Outcomes

Not specified

Similar Trials